2024-03-18T12:06:23-05:00 2023-06-30 871353108 EISNER ADVISORY GROUP LLC 733 THIRD AVENUE NEW YORK NY 100172703 990 2022-07-01 131837442 CANCER RESEARCH INSTITUTE INC CANC 2126887515 29 BROADWAY 4TH FLOOR NEW YORK NY 10006 ALFRED MASSIDAS CFO/DIR. OF HUMAN RESOURCES 2126887515 2024-03-18 1 ALFRED MASSIDAS 999009999 0 CANDICE METH P01306891 2129498700 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z JILL O'DONNELL-TORMEY 52041188 0 X WWW.CANCERRESEARCH.ORG X 1953 NY SEE ON SCHEDULE OTHE CANCER RESEARCH INSTITUTE'S MISSION IS TO SAVE MORE LIVES BYFUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FORALL TYPES OF CANCER. TO ACCOMPLISH THIS, CRI FUNDS LABORATORY,TRANSLATIONAL, AND CLINICAL RESEARCH. 34 34 32 264 0 0 28733665 31020217 0 0 4910453 1191003 31032 84039 33675150 32295259 22147895 27521822 0 0 5038504 5330368 0 0 3627815 4128317 5700473 31314716 38552663 2360434 -6257404 130438312 138008864 63733550 70013010 66704762 67995854 X SEE SCHEDULE OTHE CANCER RESEARCH INSTITUTE'S MISSION IS TO SAVE MORE LIVES BYFUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FORALL TYPES OF CANCER. TO ACCOMPLISH THIS, CRI FUNDS LABORATORY, TRANSLATIONAL, AND CLINICAL RESEARCH EFFORTS AIMED AT LEARNING HOW TO HARNESS THE POWER OF THE IMMUNE SYSTEM TO DIAGNOSE, TREAT, AND CURE CANCER. CRI ALSO COORDINATES SCIENTIFIC, MEDICAL, AND PATIENT EDUCATION CONFERENCES ON THE SUBJECTS OF IMMUNOLOGY AND IMMUNOTHERAPY, AND DISSEMINATES INFORMATION IN ENGLISH AND SPANISH ABOUT ADVANCES IN TUMOR IMMUNOLOGY TO THE MEDIA, PUBLIC, AND MEDICAL AND SCIENTIFIC COMMUNITIES. 0 0 6843957 6843957 CLINICAL ACCELERATOR GRANTS PROGRAM - SEE SCHEDULE OTHE CRI ANNA-MARIA KELLEN CLINICAL ACCELERATOR : IS AN ACTIVELY MANAGED VENTURE PHILANTHROPY PROGRAM DESIGNED TO SPEED THE DEVELOPMENT OF PROMISING NEW CANCER IMMUNOTHERAPY COMBINATIONS. THIS MODEL FACILITATES RESEARCH COLLABORATION ACROSS LEADING BIOPHARMA COMPANIES AND THE CRI NETWORK OF IMMUNO-ONCOLOGY EXPERTS. THE PROGRAM INCLUDES PLATFORM CLINICAL TRIALS THAT ARE COLLABORATIVE, INTEGRATIVE, SCIENCE/DATA-DRIVEN, AND HYPOTHESIS-ANSWERING CLINICAL STUDIES. CRI PLANS, IMPLEMENTS, INVESTS IN, AND MANAGES EACH CLINICAL ACCELERATOR CLINICAL TRIAL AND WORKS CLOSELY WITH ACADEMIC RESEARCHER AND INDUSTRY PARTNERS ON SUCH STUDIES. EACH CLINICAL TRIAL AND PHILANTHROPIC INVESTMENT BRINGS A POTENTIAL NEW CANCER TREATMENT CLOSER TO PATIENTS, EMPOWERS ACADEMIC RESEARCHERS TO WORK MORE CLOSELY WITH INDUSTRY, AND CREATES A POTENTIAL RETURN ON INVESTMENT TO BE USED TO SUPPORT FURTURE CLINICAL EFFORTS. 6572476 6572476 FELLOWSHIP PROGRAM - SEE SCHEDULE OTHE CRI POSTDOCTORAL FELLOWSHIP PROGRAM INCLUDES THREE TRACKS OF FELLOWSHIPS PROVIDING CAREER DEVELOPMENT, TRAINING, AND DIVERSITY BUILDING IN IMMUNOLOGY AND IMMUNO-INFOMATICS. THE CRI IRVINGTON POSTDOCTORAL FELLOWSHIP, CRI IRVINGTON POSTDOCTORAL FELLOWSHIP TO PROMOTE RACIAL DIVERSITY, AND THE CRI IMMUNO-INFORMATICS FELLOWSHIP EACH SUPPORT YOUNG IMMUNOLOGISTS AND CANCER IMMUNOLOGISTS AT TOP UNIVERSITIES AND RESEARCH CENTERS AROUND THE WORLD. FELLOWS RECEIVE UP TO $243,000 OVER THREE YEARS TO COVER THE COST OF STIPEND, INCLUDING AN INSTITUTIONAL ALLOWANCE TO HELP PAY FOR THE FELLOW'S RESEARCH SUPPLIES, TRAVEL TO SCIENTIFIC MEETINGS, HEALTH INSURANCE, AND/OR CHILDCARE. OF THE MORE THAN 1,550 CRI POSTDOCTORAL FELLOWS FUNDED TO DATE, MANY HAVE SINCE BECOME HEADS OF MAJOR MEDICAL RESEARCH INSTITUTES, ACADEMIC LEADERS IN PRESTIGIOUS UNIVERSITIES, AND ADMIRED MENTORS TO THE NEXT GENERATION OF IMMUNOLOGISTS AND TUMOR IMMUNOLOGISTS. 6250000 6250000 STAR PROGRAM - SEE SCHEDULE OTHE LLOYD J. OLD STAR PROGRAM, LAUNCHED IN 2019, PROVIDES GRANTS OF $1.25 MILLION OVER 5 YEARS TO MID-CAREER SCIENTISTS. THIS LONGTERM FUNDING IS NOT TIED TO A SPECIFIC RESEARCH PROJECT, BUT RATHER AIMS TO PROVIDE A DEGREE OF FLEXIBILITY AND FREEDOM FOR INVESTIGATORS TO EXPLORE OUTSIDE-THE-BOX AND DISRUPTIVE AVENUES OF RESEARCH. CANDIDATES SELECTED FOR THIS AWARD ARE EXPECTED TO BE FUTURE "STARS" IN THE FIELD OF CANCER IMMUNOLOGY: SCIENTISTS TAKING RISKS. 13178796 7855389 CRI CLINICAL INNOVATOR:THE CRI CLINICAL INNOVATOR SUPPORTS NOVEL CLINICAL STUDIES THAT ADDRESS AREAS OF HIGH UNMET NEED IN CANCER AND SEEK MECHANISTIC INSIGHTS INTO CLINICAL RESPONSE WITH A GOAL OF PREDICTIVE BIOMARKER DISCOVERY. TO MAXIMIZE THE IMPACT OF EACH CLINICAL TRIAL, CRI WILL ADVISE ON SELECTED STUDIES IN A COORDINATED EFFORT TO OPTIMIZE CLINICAL TRIAL DESIGN AND TRANSLATIONAL STUDIES. FUNDING OF UP TO $1M PER TRIAL IS AWARDED.CLINIC AND LABORATY INTEGRATION PROGRAM (CLIP):THE CRI CLINIC AND LABORATORY INTEGRATION PROGRAM (CLIP) SUPPORTS PRE-CLINICAL AND TRANSLATIONAL RESEARCH THAT CAN BE DIRECTLY APPLIED TO OPTIMIZING CANCER IMMUNOTHERAPY IN THE CLINIC. CLIP GRANTS ARE AWARDED TO QUALIFIED SCIENTISTS EXPLORING CLINICALLY RELEVANT QUESTIONS AIMED AT IMPROVING THE EFFECTIVENESS OF CANCER IMMUNOTHERAPIES. CLIP GRANTS PROVIDE UP TO $300,000 OVER TWO YEARS. TECHNOLOGY IMPACT AWARD:THE CRI TECHNOLOGY IMPACT AWARD PROVIDES SEED FUNDING OF UP TO $200,000 TO BE USED OVER 24 MONTHS TO ADDRESS THE GAP BETWEEN TECHNOLOGY DEVELOPMENT AND CLINICAL APPLICATION OF CANCER IMMUNOTHERAPIES.CRI IMPACT GRANTS:CRI IMPACT GRANTS SUPPORT RESEARCH PROJECTS AND PUBLIC EDUCATION AND AWARENESS INITIATIVES WITHIN OR APPLICABLE TO THE FIELDS OF IMMUNOLOGY AND TUMOR IMMUNOLOGY FOR WHICH FUNDS HAVE BEEN SPECIFICALLY RAISED. 13178796 7855389 32845229 1 1 0 0 0 0 0 0 0 1 1 1 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 29 0 1 32 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 34 34 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 NY AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IA IN KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WI WV WY X ALFRED MASSIDAS 2126887515 29 BROADWAY 4TH FL NEW YORK NY 10006 PAUL C SHIVERICK CHAIRMAN 4.00 X X 0 0 0 ANDREW K TSAI CHAIRMAN 4.00 X X 0 0 0 EDGAR R BERNER VICE CHAIRMAN 3.00 X X 0 0 0 DONALD J GOGEL VICE CHAIRMAN 3.00 X X 0 0 0 ANDREW M PAUL VICE CHAIRMAN 3.00 X X 0 0 0 GEOFFREY O COLEY TREASURER 3.00 X X 0 0 0 THOMAS G MENDELL SECRETARY 1.00 X X 0 0 0 TONY ALVAREZ II TRUSTEE 0.50 X 0 0 0 YACOV ARNOPOLIN TRUSTEE 3.00 X 0 0 0 PETER L BLOOM TRUSTEE 1.00 X 0 0 0 BRIAN J BRILLE TRUSTEE 1.00 X 0 0 0 MICHAEL R CRAWFORD TRUSTEE 1.00 X 0 0 0 W ROBERT DAHL TRUSTEE 1.00 X 0 0 0 GLENN J DESIMONE TRUSTEE 2.00 X 0 0 0 SEAN P FAHEY TRUSTEE 1.00 X 0 0 0 MARGOT E FREEDMAN TRUSTEE 0.50 X 0 0 0 WILLIAM S GOLDBERG TRUSTEE 0.50 X 0 0 0 OLIVER R GRACE JR TRUSTEE 1.00 X 0 0 0 SANDRA COUDERT GRAHAM TRUSTEE 1.00 X 0 0 0 MICHAEL M KELLEN TRUSTEE 2.00 X 0 0 0 SARAH KIM TRUSTEE 1.00 X 0 0 0 MITRA LOHRASBPOUR TRUSTEE (THRU 1/2023) 2.00 X 0 0 0 ALEXANDER P LYNCH TRUSTEE 1.00 X 0 0 0 ALEX MISHUROV TRUSTEE 0.50 X 0 0 0 MICHAEL J PETRICK TRUSTEE 0.50 X 0 0 0 LIEF D ROSENBLATT TRUSTEE 1.00 X 0 0 0 FRANK VSICA TRUSTEE 1.00 X 0 0 0 JAMES A STERN TRUSTEE 1.00 X 0 0 0 ROBERT S STOLAR TRUSTEE 1.00 X 0 0 0 MICHAEL B TARGOFF TRUSTEE 1.00 X 0 0 0 DIANE TUFT TRUSTEE 1.00 X 0 0 0 LAUREN SVERONIS TRUSTEE 3.00 X 0 0 0 RONALD G WEINER TRUSTEE 1.00 X 0 0 0 JIM WEISS TRUSTEE 2.00 X 0 0 0 PETER ZHOU TRUSTEE 2.00 X 0 0 0 JILL O'DONNELL-TORMEY PHD CEO/DIR. OF SCIENTIFIC AFFAIRS 40.00 X 531286 0 71017 ALFRED R MASSIDAS CFO/DIR. OF HUMAN RESOURCES 40.00 X 342586 0 83215 LYNNE A RAPINO CHIEF PROGRAM OFFICER 40.00 X 283374 0 80930 JAY R CAMPBELL MANAGING DIR. OF CRI CLINICAL ACCELERATOR AND VENT 40.00 X 274937 0 80466 SHARON S SLADE CHIEF MARKETING OFFICER 40.00 X 259188 0 46322 BRIAN M BREWER CHIEF COMMUNICATIONS OFFICER 40.00 X 206106 0 41493 RUPINDER KAUR CHIEF INFORMATION OFFICER 40.00 X 224014 0 61474 QING HUA ZHANG CONTROLLER 40.00 X 140888 0 50907 MARLA S LAWSON ASSOC. DIR. OF CORPORATE AND FOUNDATION RELATIONS 40.00 X 130597 0 49766 SAMIK K UPADHAYA ASST. DIR. OF SCIENTIFIC AFFAIRS 40.00 X 130644 0 50413 BRIAN R LEIDY CHIEF DEVELOPMENT OFFICER 40.00 X 199545 0 29070 DEANNE T MARBACH DIRECTOR OF MAJOR GIFTS 40.00 X 149175 0 51949 2872340 0 697022 15 0 1 0 SOCIEDAD ADVERTISING 20 STUYVESANT OVAL 7F NEW YORK NY 10009 PATIENT SUMMIT 627140 PAULO SIMAS 10 CANDLELIGHT LANE LAFAYETTE CA 94549 BRAND DEVELOPMENT 120000 2 573941 1297284 29148992 574281 31020217 644951 644951 168009 138690 29319 29319 29319 20050443 19504391 546052 546052 546052 102848 1297284 102848 0 MISCELLANEOUS REVENUE 900099 54720 54720 54720 32295259 54720 0 1220322 25067892 25067892 2453930 2453930 2353418 844830 613684 894904 1675895 596534 190044 889317 314864 116963 72737 125164 748601 286807 146686 315108 237590 86251 45366 105973 18783 11713 7070 100926 100926 441768 441768 1014995 622192 15500 377303 224254 55941 168313 258995 89929 68060 101006 467073 197004 107427 162642 147021 65163 24475 57383 2187368 2187368 41992 16797 9238 15957 51609 51609 EQUIPMENT RENTAL AND MA 448588 112465 33051 303072 MISCELLANEOUS 181013 24161 127149 29703 PRINTING AND PUBLICATIO 91259 9289 81970 FILING FEE 24829 24829 38552663 32845229 2079619 3627815 14456208 14783358 0 1903578 28317202 25188717 39970 160297 426189 288340 671733 558617 142209 113116 22457949 26380379 64598585 66740812 0 2450267 130438312 138008864 712546 667567 62989463 66778175 31541 2567268 63733550 70013010 X 42501270 44693823 24203492 23302031 66704762 67995854 130438312 138008864 X -6257404 4810924 2737572 X 0 1 X 1 0 X 40376590 35256709 32869987 28733665 31020217 168257168 40376590 35256709 32869987 28733665 31020217 168257168 39980094 128277074 441074 621444 274125 569941 674270 2580854 465 7073 37398 44936 142978 1154 25594 9556 54720 234002 171116960 0.74960 0.70500 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME OTHER INCOME FOR CANCER RESEARCH INSTITUTE CONSISTS OF CREDIT CARD CASH BACK AND OTHER INCOME TO THE INSTITUTE RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 9852169 23500 883179 10758848 10885794 19500 -1053125 9852169 8309311 24180 2552303 10885794 8200942 21700 297442 210773 8309311 7939697 33734 377937 150426 8200942 0.57000 0.33000 0.10000 0 0 110205 56161 54044 561528 502456 59072 113116 PRIVATE EQUITY 36386355 F HEDGE FUNDS 8460278 F FUND OF FUNDS 21894179 F 66740812 OPERATING LEASE LIABILITY 2535727 REFUNDABLE SECURITY DEPOSIT 31541 2567268 X 39886855 4810924 501480 122268 2598692 8033364 31853491 441768 441768 32295259 38612375 501480 501480 38110895 441768 441768 38552663 PART V, LINE 4: THE INSTITUTE'S ENDOWMENT CONSISTS OF FOUR DONOR-RESTRICTED FUNDS AND A BOARD DESIGNATED FUND ESTABLISHED TO SUPPORT FELLOWSHIPS AND OTHER RESEARCH PROGRAMS. PART X, LINE 2: THE INSTITUTE IS SUBJECT TO THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD'S (THE "FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") TOPIC 740, INCOME TAXES, AS IT RELATES TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. BECAUSE OF THE INSTITUTE'S GENERAL TAX-EXEMPT STATUS, MANAGEMENT BELIEVES ASC TOPIC 740 HAS NOT HAD, AND IS NOT ANTICIPATED TO HAVE, A MATERIAL IMPACT ON THE FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: CANCELLATION OF GRANTS 2,598,692. 1 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS 1058274 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS 1177356 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS 218300 CENTRAL AMERICA AND THE CARIBBEAN - ANTIGUA & BARBUDA, ARUBA, BAHAMAS, 0 0 INVESTMENTS 63617257 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 INVESTMENTS 1889466 0 0 0 0 0 0 67960653 0 67960653 EAST ASIA AND THE PACIFIC RESEARCH 200000 ACH/WIRE 0 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, RESEARCH 658274 ACH/WIRE 0 EAST ASIA AND THE PACIFIC RESEARCH 200000 ACH/WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 200000 ACH/WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 200000 ACH/WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 200000 ACH/WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 200000 ACH/WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 243000 ACH/WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 102256 ACH/WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 17300 ACH/WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 14800 ACH/WIRE 0 NORTH AMERICA RESEARCH 202800 ACH/WIRE 0 NORTH AMERICA RESEARCH 15500 ACH/WIRE 0 13 0 1 0 0 0 1 0 PART I, LINE 2: CANCER RESEARCH INSTITUTE INC. REQUIRES GRANT RECIPIENTS TO COMPLY WITH STATED TERMS AND CONDITIONS GOVERNING EACH PROGRAM, INCLUDING THE SUBMISSION OF ANNUAL PROGRESS REPORTS AND, WHERE APPLICABLE, INSTITUTION-GENERATED FINANCIAL REPORTS. DISBURSEMENT OF FUNDS IS CONTINGENT UPON ACCEPTANCE OF THESE TERMS AND TIMELY SUBMISSION OF REPORTS. PART I, LINE 3: AMOUNTS ARE REPORTED ON THE ACCRUAL BASIS. PART III ACCOUNTING METHOD: THROUGH THE KITCHEN 952008 849160 102848 102848 LANDESMAN LADIES NIGHT OUT 279616 279616 2 168508 168508 1400132 1297284 102848 102848 102848 0 1 HARVARD UNIVERSITY 16 DIVINITY AVENUE CAMBRIDGE MA 02138 042103580 501C(3) 688800 0 RESEARCH MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVENUE CAMBRIDGE MA 021394307 042103594 501C(3) 14800 0 RESEARCH DANA-FARBER CANCER INSTITUTE INC 450 BROOKLINE AVENUE BOSTON MA 02115 042263040 501C(3) 1535000 0 RESEARCH BRIGHAM & WOMEN'S HOSPITALHARVARD MEDICAL SCHOOL 75 FRANCIS STREET BOSTON MA 02115 042312909 501C(3) 437300 0 RESEARCH BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501C(3) 475100 0 RESEARCH YALE UNIVERSITY SCHOOL OF MEDICINE PO BOX 208055 333 CEDAR STREET NEW HAVEN CT 065208055 060646973 501C(3) 529695 0 RESEARCH WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVENUE NEW YORK NY 10065 131623978 501C(3) 6600 0 RESEARCH THE ROCKEFELLER UNIVERSITY 1230 YORK AVENUE NEW YORK NY 10065 131624158 501C(3) 288350 0 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501C(3) 1112850 0 RESEARCH NEW YORK UNIVERSITY MEDICAL CENTER 550 FIRST AVENUE NEW YORK NY 10016 135562309 501C(3) 19350 0 RESEARCH COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 701 W 168TH STREET NEW YORK NY 10032 135598093 501C(3) 1250000 0 RESEARCH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 1425 MADISON AVENUE BOX 1630 NEW YORK NY 10029 136171197 501C(3) 1464497 0 RESEARCH UNIVERSITY OF PENNSYLVANIA 3400 CIVIC CENTER BLVD PHILADELPHIA PA 19104 231352685 501C(3) 37400 0 RESEARCH AMERICAN ASSOCIATION FOR CANCER RESEARCH 15 CHESTNUT STREET PHILADELPHIA PA 19106 236251648 501C(3) 100000 0 RESEARCH FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 237156071 501C(3) 12150 0 RESEARCH THE UNIVERSITY OF PITTSBURGH 107 CATHEDRAL OF LEARNING PITTSBURGH PA 15260 250965591 501C(3) 10500 0 RESEARCH UNIVERSITY OF WISCONSIN-MADISON 21 N PARK STREET MADISON WI 53715 396006492 501C(3) 13800 0 RESEARCH UNIVERSITY OF MINNESOTA 100 CHURCH STREET SE MINNEAPOLIS MINNEAPOLIS MN 55455 416007513 501C(3) 452600 0 RESEARCH PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY ONE LETTERMAN DRIVE SAN FRANCISCO CA 94129 473355381 501C(3) 750000 0 RESEARCH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES 4 CENTER DRIVE BETHESDA MD 208920460 520858115 NIAID 10500 0 RESEARCH H LEE MOFFITT CANCER CENTER 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501C(3) 10500 0 RESEARCH THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BLVD DALLAS TX 753909002 756002868 501C(3) 445800 0 RESEARCH UNIVERSITY OF WASHINGTON 1959 NE PACIFIC STREET SEATTLE WA 98195 916001537 501C(3) 429000 0 RESEARCH STANFORD UNIVERSITY 291 CAMPUS DRIVE STANFORD CA 94305 941156365 501C(3) 10500 0 RESEARCH UNIVERSITY OF CALIFORNIA SAN FRANCISCO 513 PARNASSUS AVENUE SAN FRANCISCO CA 94122 946036493 501C(3) 1128550 0 RESEARCH SALK INSTITUTE THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 10010 NORTH TORREY PINES ROAD LA JOLLA CA 92037 952160097 501C(3) 224300 0 RESEARCH UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DRIVE LA JOLLA CA 92093 956006144 501C(3) 24850 0 RESEARCH SURGE 700 MAIN STREET CAMBRIDGE MA 02139 300961988 89504 0 RESEARCH BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 77030 741613878 501C(3) 386000 0 RESEARCH EMORY UNIVERSITY 1510 CLIFTON ROAD ATLANTA GA 30322 580566256 501C(3) 1250000 0 RESEARCH JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE 401 N BROADWAY BALTIMORE MD 21231 520595110 501C(3) 9002197 0 RESEARCH THE LA JOLLA INSTITUTE FOR IMMUNOLOGY 9420 ATHENA CIRCLE LA JOLLA CA 92037 330328688 501C(3) 202800 0 RESEARCH MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 041564655 501C(3) 402800 0 RESEARCH NORTHWESTERN UNIVERSITY 750 N LAKE SHORE DRIVE CHICAGO IL 60513 362167817 501C(3) 200000 0 RESEARCH OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK RD PORTLAND OR 972013098 931176109 501C(3) 405600 0 RESEARCH SURVEY GENOMICS 2625 DURANT AVE BERKELEY CA 94720 300961988 99999 0 RESEARCH THE J DAVID GLADSTONE INSTITUTES 1650 OWENS STREET SAN FRANCISCO CA 94158 237203666 501C(3) 243000 0 RESEARCH THE SCRIPPS RESEARCH INSTITUTE 10550 NORTH TORREY PINES ROAD LA JOLLA CA 92037 133043595 501C(3) 202800 0 RESEARCH ALBERT EINSTEIN COLLEGE OF MEDICINE 1300 MORRIS PARK AVENUE STE 312 BRONX NY 10461 162425500 501C(3) 243000 0 RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 77030 746001118 501C(3) 200000 0 RESEARCH UNIVERSITY OF CALIFORNIA BERKELEY 200 CALIFORNIA HALL BERKELEY CA 94720 946002123 501C(3) 7200 0 RESEARCH UNIVERSITY OF CHICAGO MEDICAL CENTER 5841 S MARYLAND AVENUE CHICAGO IL 60637 136217139 501C(3) 200000 0 RESEARCH UNIVERSITY OF COLORADO AT BOULDER 596 UCB BOULDER CO 80309 846000555 501C(3) 7200 0 RESEARCH UNIVERSITY OF VIRGINIA HEALTH SYSTEM PO BOX 800712 CHARLOTTESVILLE VA 22908 546001796 501C(3) 200000 0 RESEARCH WASHINGTON UNIVERSITY SCHOOL OF MEDICINE 660 S EUCLID AVENUE ST LOUIS MO 63110 430653611 501C(3) 243000 0 RESEARCH 43 2 PART I, LINE 2: CANCER RESEARCH INSTITUTE INC. REQUIRES GRANT RECIPIENTS TO COMPLY WITH STATED TERMS AND CONDITIONS GOVERNING EACH PROGRAM, INCLUDING THE SUBMISSION OF ANNUAL PROGRESS REPORTS AND, WHERE APPLICABLE, INSTITUTION-GENERATED FINANCIAL REPORTS. DISBURSEMENT OF FUNDS IS CONTINGENT UPON ACCEPTANCE OF THESE TERMS AND TIMELY SUBMISSION OF REPORTS. X X X 0 0 0 0 0 0 0 0 0 JILL O'DONNELL-TORMEY PHD CEO/DIR. OF SCIENTIFIC AFFAIRS 531286 0 0 0 0 0 34500 0 36517 0 602303 0 0 0 ALFRED R MASSIDAS CFO/DIR. OF HUMAN RESOURCES 342586 0 0 0 0 0 31250 0 51965 0 425801 0 0 0 LYNNE A RAPINO CHIEF PROGRAM OFFICER 283374 0 0 0 0 0 29000 0 51930 0 364304 0 0 0 JAY R CAMPBELL MANAGING DIR. OF CRI CLINICAL ACCELE 274937 0 0 0 0 0 28500 0 51966 0 355403 0 0 0 SHARON S SLADE CHIEF MARKETING OFFICER 259188 0 0 0 0 0 27500 0 18822 0 305510 0 0 0 RUPINDER KAUR CHIEF INFORMATION OFFICER 224014 0 0 0 0 0 25000 0 36474 0 285488 0 0 0 BRIAN M BREWER CHIEF COMMUNICATIONS OFFICER 206106 0 0 0 0 0 10937 0 30556 0 247599 0 0 0 BRIAN R LEIDY CHIEF DEVELOPMENT OFFICER 199545 0 0 0 0 0 0 0 29070 0 228615 0 0 0 DEANNE T MARBACH DIRECTOR OF MAJOR GIFTS 149175 0 0 0 0 0 15600 0 36349 0 201124 0 0 0 QING HUA ZHANG CONTROLLER 140888 0 0 0 0 0 14600 0 36307 0 191795 0 0 0 SAMIK K UPADHAYA ASST. DIR. OF SCIENTIFIC AFFAIRS 130644 0 0 0 0 0 14100 0 36313 0 181057 0 0 0 MARLA S LAWSON ASSOC. DIR. OF CORPORATE AND FOUNDAT 130597 0 0 0 0 0 13500 0 36266 0 180363 0 0 0 X 32 574281 FAIR MARKET VALUE 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE CEO AND THE CFO WORK WITH THE AUDIT FIRM TO PREPARE THE TAX RETURNS. A DRAFT COPY IS CIRCULATED TO THE ENTIRE BOARD FOR REVIEW AND COMMENTS, AFTER WHICH IT IS SIGNED AND FILED WITH RELEVANT AUTHORITIES. FORM 990, PART VI, SECTION B, LINE 12C ALL MEMBERS OF THE BOARD AND THE ENTIRE STAFF ARE GIVEN THE CONFLICT OF INTEREST DOCUMENT. THEY ARE ASKED TO ANSWER ALL QUESTIONS AND MAKE THE NECESSARY DECLARATIONS AND THEN SIGN THE DOCUMENT ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS FOR DETERMINING COMPENSATION OF THE CEO IS DETERMINED BY USING COMPARABLE DATA AND IS REVIEWED BY THE BOARD OF TRUSTEES CO-CHAIRMEN. FORM 990, PART VI, SECTION C, LINE 19 AT LEAST THE THREE MOST RECENT YEARS OF FINANCIAL INFORMATION ARE POSTED ON CRI'S WEBSITE. THE GENERAL PUBLIC CAN ALSO REQUEST A COPY TO BE SENT TO THEM, AS WELL AS VIEW THEM AT OUR OFFICES AT 29 BROADWAY, 4TH FLOOR NEW YORK, NY 10006. GOVERNING DOCUMENTS ARE ONLY DISTRIBUTED INTERNALLY TO MANAGEMENT AND THE BOARD OF TRUSTEES. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF PERPETUAL TRUST 16,612. CANCELLATION OF GRANTS 2,598,692. GRANT REFUNDS 122,268. CANCER VACCINE ACCELERATION CO 605 THIRD AVENUE 32ND FLOOR NEW YORK NY 10158 RESEARCH DE CRI 0 1 0.50000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0